Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Accumulated Expenses (2018 - 2026)

TELA Bio has reported Other Accumulated Expenses over the past 8 years, most recently at $711000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 48.43% year-over-year to $711000.0; the TTM value through Dec 2025 reached $711000.0, up 48.43%, while the annual FY2025 figure was $711000.0, 48.43% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $711000.0 at TELA Bio, down from $1.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.2 million in Q2 2025 and troughed at $51000.0 in Q1 2022.
  • A 5-year average of $475550.0 and a median of $378500.0 in 2023 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 6744.44% in 2021 and later plummeted 91.72% in 2022.
  • Year by year, Other Accumulated Expenses stood at $79000.0 in 2021, then skyrocketed by 84.81% to $146000.0 in 2022, then skyrocketed by 260.96% to $527000.0 in 2023, then decreased by 9.11% to $479000.0 in 2024, then surged by 48.43% to $711000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for TELA at $711000.0 in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.